These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20363765)

  • 41. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
    Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
    EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis.
    Ako J; Morino Y; Honda Y; Hassan A; Sonoda S; Yock PG; Leon MB; Moses JW; Bonneau HN; Fitzgerald PJ
    J Am Coll Cardiol; 2005 Sep; 46(6):1002-5. PubMed ID: 16168282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.
    Radu MD; Räber L; Kalesan B; Muramatsu T; Kelbæk H; Heo J; Jørgensen E; Helqvist S; Farooq V; Brugaletta S; Garcia-Garcia HM; Jüni P; Saunamäki K; Windecker S; Serruys PW
    Eur Heart J; 2014 Mar; 35(12):795-807. PubMed ID: 24132187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
    Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
    Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography.
    Tian F; Chen YD; Sun ZJ; Chen L; Yuan F; Song XT; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(6):670-4. PubMed ID: 19323932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
    Gomez-Lara J; Brugaletta S; Diletti R; Garg S; Onuma Y; Gogas BD; van Geuns RJ; Dorange C; Veldhof S; Rapoza R; Whitbourn R; Windecker S; Garcia-Garcia HM; Regar E; Serruys PW
    Eur Heart J; 2011 Feb; 32(3):294-304. PubMed ID: 21123276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis.
    Sato T; Tölg R; El-Mawardy M; Sulimov DS; Richardt G; Abdel-Wahab M
    J Cardiol; 2017 Nov; 70(5):454-460. PubMed ID: 28476635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Roy P; Steinberg DH; Sushinsky SJ; Okabe T; Pinto Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Weissman NJ; Lindsay J; Waksman R
    Eur Heart J; 2008 Aug; 29(15):1851-7. PubMed ID: 18550555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
    Cook S; Ladich E; Nakazawa G; Eshtehardi P; Neidhart M; Vogel R; Togni M; Wenaweser P; Billinger M; Seiler C; Gay S; Meier B; Pichler WJ; Jüni P; Virmani R; Windecker S
    Circulation; 2009 Aug; 120(5):391-9. PubMed ID: 19620501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
    Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.
    Weissman NJ; Turco MA; Ormiston JA; Mann T; Cannon LA; McGarry TF; Webster MW; Hall JJ; Lucca MJ; Mishkel GJ; Wu CJ; Mandinov L; Dawkins KD
    Cardiovasc Revasc Med; 2011; 12(4):247-57. PubMed ID: 21130708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
    Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
    EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.